December 20, 2015 / 12:32 PM / 4 years ago

REFILE-BRIEF-Shanghai Fosun Pharma's unit plans Hong Kong share offering

(Refiles to fix headline)

Dec 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says board approves unit Yaneng Biotechnology’s initial public offering (IPO) in Hong Kong

* Says expects Yaneng Biotechnology to issue 40 million shares

Source text in Chinese: bit.ly/1musFwD

Further company coverage: (Reporting by Hong Kong and Singapore newsrooms)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below